載入...
Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring
Circulating cell-free DNA (cfDNA) released by tumor cells, termed ctDNA, closely reflects the heterogeneity of primary cancers and their metastases. As a noninvasive, real-time monitoring biomarker, ctDNA is a promising tool for detecting driver gene mutations, assessing tumor burden and acquired re...
Na minha lista:
| 發表在: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5644666/ https://ncbi.nlm.nih.gov/pubmed/29066904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S141991 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|